Platform
Monitoring Authority
Six layers of continuous intelligence coverage across the global pharmaceutical supply chain.
Situational Awareness for Critical Medicine Supply
NORSINCOM's monitoring authority spans the full pharmaceutical supply chain lifecycle — from raw material extraction and API synthesis through to finished-dose manufacturing, logistics, and distribution. Our intelligence infrastructure is designed to detect disruption signals at the earliest possible stage.
Unlike reactive shortage registries that document disruptions after they occur, NORSINCOM operates as a forward-looking intelligence function — identifying concentration risks, regulatory signals, and logistics stress before they translate into clinical shortages.
Request Intelligence Access
Monitoring Layers
Six-Layer Coverage Architecture
API & Raw Material Surveillance
Continuous monitoring of active pharmaceutical ingredient manufacturing hubs across India, China, and Europe. Covers synthesis capacity, regulatory compliance status, and export restrictions.
Facility Risk Intelligence
Real-time risk scoring for 847+ monitored manufacturing facilities. Each facility profile tracks GMP compliance history, inspection outcomes, capacity utilization, and ownership concentration.
Logistics & Trade Flow Monitoring
Port congestion indices, shipping lane disruption tracking, and export policy monitoring across 62 countries. Identifies downstream supply delays 30–60 days before clinical impact.
Geopolitical Risk Assessment
Monitoring of geopolitical developments that affect pharmaceutical supply routes — including trade tensions, conflict zones, sanctions, and diplomatic disruptions.
Shortage Escalation Detection
Proprietary early-warning models that aggregate supply signals to forecast shortage probability by drug, therapeutic class, and region — with 30–90 day lead time.
Response Advisory Capabilities
When shortage signals reach threshold, NORSINCOM activates advisory protocols — including procurement contingency guidance, alternative supplier identification, and client briefings.